A Leading Hedge Fund Just Placed Massive Bets on Broadcom and Intel Stocks. Should You Follow Suit?

Coatue Management increased its Broadcom stake by 6% in Q2 to ~4.5% of the fund and initiated Intel at ~3.5%, betting on major 2027 growth. Broadcom’s custom AI ASIC business is guided toward >$100B revenue in 2027, while Intel’s foundry turnaround is supported by foundry revenue up 31% in Q2 and overall revenue up 25%, alongside $7B cash from operations. Valuation is split: Broadcom trades at ~18x forward earnings vs Intel at ~43x, implying the market may be underpricing AVGO’s 2027 upside but overpricing INTC’s path to profits.

Analysis

The key setup is not “AI semis good” but a timing mismatch between who owns the next leg of economics and who is already paid for it. AVGO’s custom silicon business is a platform shift: once hyperscalers commit engineering resources, the moat moves from merchant chip performance to system-level integration, which tends to expand wallet share and reduce price elasticity over time. The near-term market may still underwrite it as a cyclical networking/semis name, leaving room for multiple expansion if 2027 design-ins convert to visible revenue.

INTC is the harder trade because the stock is now pricing a credible turnaround before the turnaround is self-funding. Foundry recovery stories usually look best when utilization, yields, and external customer mix all improve together; if any one of those lags, revenue growth can coexist with weak equity returns because capex and depreciation stay ahead of cash conversion. That makes INTC more sensitive to any delay in customer commitments than the headline growth rate suggests.

Second-order, AVGO’s custom AI silicon is not simply a winner for Broadcom; it is a margin transfer from the general-purpose GPU stack toward lower-cost, workload-specific compute. That is constructive for hyperscaler capex efficiency, but it pressures some adjacent semiconductor vendors whose upside depends on perpetually rising accelerator pricing. The contrarian view is that the market may be underestimating how slow 2027 revenue actually looks from today—so AVGO could work as a stock, but not necessarily as a near-term catalyst trade until customers and packaging capacity become visible in orders.

Key Decisions for Investors

• Long AVGO / short INTC as a 6-12 month relative-value pair: AVGO has better forward growth-to-valuation math with fewer execution steps, while INTC’s rerating already assumes a successful foundry inflection. Falsify if INTC posts a surprise external foundry win with margin uplift, or if AVGO’s AI guide slips.
• Buy AVGO on pullbacks rather than chasing strength; use a 2027-2028 horizon and prefer call spreads if you want convexity. The thesis needs no immediate quarter-to-quarter beat, but it does require sustained hyperscaler design-win confirmations over the next 1-3 earnings cycles.
• Avoid initiating a fresh long INTC until there is evidence of external foundry utilization and gross margin leverage, not just top-line growth. If you must express exposure, use a smaller position or put spread as a hedge against a growth-multiple unwind over the next 1-2 quarters.
• Watch NVDA and SMH as second-order hedges: if custom ASIC adoption accelerates faster than expected, the market may rotate some AI spend away from merchant accelerators. That is not an outright short signal on NVDA today, but it is a reason to avoid paying peak multiples for the highest-duration AI names.